Clinical Trials on Organ Protection in New Zealand

Total 7267 results

University of Rochester

Completed

Effect of Music on Breastmilk

Breast Milk Production

United States
Murdoch Childrens Research Institute
Royal Children's Hospital

Completed

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Primary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2

Australia, New Zealand
University of Auckland, New Zealand

Unknown

The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study

Endometriosis | In Vitro Fertilization Implantation Failure

New Zealand
Brigham and Women's Hospital
Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital

Recruiting

Transparent Elastomeric Respirator for Aerosol-based Protection

Personal Protective Equipment

United States
GlaxoSmithKline

Completed

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Kidney Disease

New Zealand
The Fertility Centre, New Zealand

Completed

Local Anaesthetic for Transvaginal Egg Collection in IVF

Infertility

New Zealand
Hoffmann-La Roche

Completed

A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)

End Stage Renal Disease

New Zealand
The Medicines Company

Completed

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

Renal Impairment

New Zealand
University of Auckland, New Zealand
Auckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...

Completed

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene (PCOSMIC)

Polycystic Ovary Syndrome

New Zealand
Academy of Nutrition and Dietetics

Completed

Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?

End Stage Renal Disease Requiring Hemodialysis

New Zealand
Auckland District Health Board
Novartis; University of Auckland, New Zealand; IGENZ, Ltd., Auckland

Unknown

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC (DILIGENCE-1)

Clear Cell Renal Cell Carcinoma

New Zealand
ProstaCare Singapore Pte. Ltd.

Terminated

To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.

Benign Prostatic Hyperplasia

Singapore, New Zealand
Arrowhead Pharmaceuticals

Recruiting

Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease

IgA Nephropathy

New Zealand
Gilead Sciences

Completed

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

HIV

United States, New Zealand
Spero Therapeutics
United States Department of Defense

Completed

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Renal Impairment

New Zealand
Christchurch Hospital

Unknown

How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine?

Diabetes Mellitus, Type 2

New Zealand
Gilead Sciences

Completed

Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant

Chronic Hepatitis B

New Zealand
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Recurrent Genital Herpes Simplex Type 2

New Zealand
Ferring Pharmaceuticals

Terminated

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (MERMAID)

Preterm Delivery | Inadequate Milk Production

United States
Glasgow Caledonian University
University of Otago; University of Birmingham; University of Aberdeen; Aberdeen... and other collaborators

Completed

A Study of the Effects of Physiotherapy to Prevent Pelvic Organ Prolapse (PREVPROL)

Pelvic Organ Prolapse

United Kingdom, New Zealand
MedImmune LLC

Completed

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects

Renal Insufficiency

New Zealand, Germany
Australian and New Zealand Intensive Care Research...
Baxter Healthcare Corporation

Completed

Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Trial

Critical Illness | Multiple Organ Failure

Australia, New Zealand
Takeda

Completed

A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

United States
Austin Health

Terminated

Bicarbonate in Cardiac Surgery

Acute Kidney Injury

New Zealand, Australia
University Hospital, Essen

Recruiting

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors (ART in HNT)

Head and Neck Cancer | Optimized Treatment | Radiation | Adaptive Radiotherapy | Protection of Organs at Risk | Dysphagia Reduction

Germany
Monash Medical Centre
Monash University; University of Auckland, New Zealand; Hudson Institute of Medical... and other collaborators

Recruiting

Anakinra for Preterm Infants Pilot

Inflammation | Prematurity; Extreme

Australia, New Zealand
Zenflow, Inc.

Unknown

The Zenflow Spring System Feasibility and Safety Study (ZEST)

Benign Prostatic Hyperplasia

Bulgaria, New Zealand
University of Auckland, New Zealand
Counties Manukau Health; Auckland Medical Research Foundation; Auckland District... and other collaborators

Unknown

Cyclophosphamide in Lupus Nephritis

Systemic Lupus Erythematosus

New Zealand
AbbVie

Completed

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

Renal Impairment

United States, New Zealand
Zenflow, Inc.

Recruiting

The Zenflow Spring System EU Safety and Performance Study (ZEST EU)

Benign Prostatic Hyperplasia

Australia, New Zealand
Arthrosi Therapeutics
Iqvia Pty Ltd

Completed

Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment

Renal Impairment

United States, New Zealand
Antisoma Research

Completed

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Metastatic Renal Cell Carcinoma | Metastatic Malignant Melanoma

United Kingdom, New Zealand
Resurge Therapeutics Inc.

Recruiting

RT-310 Dose Escalation BPH Study

Lower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)

New Zealand, Australia
Biosense Webster, Inc.

Completed

RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 (RENABLATE-II)

Hypertension, Renal

Czech Republic, Italy, New Zealand, Spain
Alessa Therapeutics Inc.

Completed

A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer (Biolen-PC)

Lower Urinary Tract Symptoms | Prostate Adenocarcinoma

United States, Australia, New Zealand
Gilead Sciences

Completed

Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function

Inflammatory Disease

United States, New Zealand, Germany
Light Sciences Oncology

Completed

Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

New Zealand, Australia
Alexion
Achillion, a wholly owned subsidiary of Alexion

Completed

A Long-Term Treatment Study of ACH-0144471 in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria

New Zealand, Korea, Republic of, Italy
Heinrich-Heine University, Duesseldorf

Completed

Sunscreen RV 2457C in Photoinduced CLE

Skin Lesion | Cutaneous Lupus Erythematosus | Experimental Photoinduction | Protective Sunscreen

Germany
GT Urological, LLC

Completed

Clinical Investigation of GT UrologIcal, LLC's Artificial Urinary Sphincter (RELIEF II) (RELIEFII)

Male Stress Urinary Incontinence

Australia, Czechia, New Zealand
Apellis Pharmaceuticals, Inc.

Completed

Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects. (PADDOCK)

Paroxysmal Nocturnal Hemoglobinuria

Hong Kong, Thailand, New Zealand, Malaysia
Noxopharm Limited

Completed

Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate Cancer

Cancer

New Zealand, Georgia, Australia
Escient Pharmaceuticals, Inc
Novotech (Australia) Pty Limited

Completed

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

Pruritus | Cholestasis | Kidney Failure

Australia, New Zealand
Holbaek Sygehus

Enrolling by invitation

Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment (PRESERVE)

End Stage Renal Disease | Peritoneal Dialysis Complication

Denmark
ViiV Healthcare

Completed

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

HIV Infections

United States, New Zealand
Progyny, Inc.

Unknown

Eeva System Imaging Study (PROSPECT)

Infertility

United States, New Zealand
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

HCV Infection

United States, New Zealand, Germany
Bristol-Myers Squibb

Terminated

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types (CheckMate 76U)

Tumor

Italy, United States, New Zealand
University of British Columbia

Completed

Predicting Complications in Women With Toxaemia

Toxemia

United Kingdom, Canada, New Zealand
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, New Zealand, Korea, Republic of, Italy

Clinical Trials on Organ Protection in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations